Kieren J. Mather
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Diabetes, Cardiovascular Risks, and Lipoproteins, Pancreatic function and diabetes
Most-Cited Works
- → Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans(2000)3,776 cited
- → Cardiovascular consequences of metabolic syndrome(2017)529 cited
- → Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study(2012)524 cited
- → Improved endothelial function with metformin in type 2 diabetes mellitus(2001)512 cited
- → β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment(2014)456 cited
- → Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity(2023)395 cited
- → Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications(2001)356 cited
- → Obesity, Insulin Resistance, and the Metabolic Syndrome(2005)318 cited
- → Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes(2002)227 cited
- → Long‐term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study(2012)216 cited